SVP, CFO and Treasurer of Acceleron Pharma Inc (30-Year Financial, Insider Trades) Kevin F Mclaughlin (insider trades) sold 54,000 shares of XLRN on 04/09/2020 at an average price of $86.37 a share. The total sale was $4.7 million.
Acceleron Pharma Inc is a biotechnology company which focuses on discovery, development, and commercialization of novel therapies. It aims to discover key natural regulators of cellular growth and repair. Acceleron Pharma Inc has a market cap of $4.74 billion; its shares were traded at around $88.87 with and P/S ratio of 63.48. GuruFocus has detected 4 severe warning signs with Acceleron Pharma Inc. .
CFO Recent Trades:
- SVP, CFO and Treasurer Kevin F Mclaughlin sold 54,000 shares of XLRN stock on 04/09/2020 at the average price of $86.37. The price of the stock has increased by 2.89% since.
Directors and Officers Recent Trades:
- SVP, General Counsel and Sec. Adam M Veness sold 6,000 shares of XLRN stock on 04/08/2020 at the average price of $85.58. The price of the stock has increased by 3.84% since.
For the complete insider trading history of XLRN, click here
.